Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

GELS stock hub

Gelteq Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GELSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GELS

In the news

Latest news · GELS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-43

P25 -105.6P50 -46.5P75 -3.1

ROIC-16.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GELS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

AUD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001920092
Company name	Gelteq Limited
Country	Australia
Country code	US
Employees	8
Employees Change	5%
Employees Change Percent	166.7
Enterprise value	$7.6M
Exchange	NASDAQ
Financial currency	AUD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2024-10-29
Isin	AU0000218109
Last refreshed	2026-05-10
Market cap	$5M
Market cap category	Nano-Cap
Price	$0.47
Price currency	USD
Rev Per Employee	33,856.63x
Sector	Healthcare
Sic	2834
Symbol	GELS
Website	https://www.gelteq.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-86.54%
EV/Sales	27.96x
FCF yield	-79.58%
P/B ratio	0.45x
P/S ratio	18.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	72.07%
Gross Profit	$195,198
Net Income	$-4.4M
Net Income Growth Years	0%
Pretax Margin	-1,608.55%
Profit Per Employee	$-544,602
ROA	-15
Roa5y	-8.3
ROCE	-31.98
ROE	-42.99
Roe5y	-20.44
ROIC	-16.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-66.21%
EPS Growth Years	0
Revenue Growth	188.27x
Revenue Growth Q	53.11x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$14.1M
Cash	$225,954
Current Assets	$1.1M
Current Liabilities	$4.1M
Debt	$2.8M
Debt Equity	$0.27
Equity	$10.4M
Interest Coverage	-2.67
Liabilities	$3.7M
Long Term Assets	$13M
Long Term Liabilities	$-366,116
Net Cash	$-2.5M
Net Cash By Market Cap	$-50.44
Net Debt Equity	$0.25
Tangible Book Value	$-2.7M
Tangible Book Value Per Share	$-0.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.27
Net Working Capital	$-174,556
Quick ratio	0.14
Working Capital	$-2.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.22%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-66.19%
200-day SMA	1.04
50-day SMA	0.7
50-day SMA vs 200-day SMA	50under200
All Time High	5.5
All Time High Change	-91.45%
All Time High Date	2024-12-10
All Time Low	0.44
All Time Low Change	7.11%
All Time Low Date	2026-05-06
ATR	0.06
Beta1y	2.28
Beta2y	2.72
Ch YTD	-41.25
High	0.48
High52	3.51
High52 Date	2025-06-10
High52ch	-86.61%
Low	0.46
Low52	0.44
Low52 Date	2026-05-06
Low52ch	7.11%
Ma50ch	-33.08%
Premarket Change Percent	4.72
Premarket Price	$0.49
Premarket Volume	469
Price vs 200-day SMA	-54.98%
RSI	28.86
RSI Monthly	29.54
RSI Weekly	27.15
Sharpe ratio	-0.22x
Sortino ratio	-0.39
Total Return	-14.22%
Tr YTD	-41.25
Tr1m	-29.41%
Tr1w	-28.56%
Tr3m	-41.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-3.3M
Operating margin	-1,226.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,678,275%
Float Percent	43.68%
Net Borrowing	350,056.6
Shares Insiders	30.95%
Shares Institutions	6.7%
Shares Out	10,711,059
Shares Qo Q	15.12%
Shares Yo Y	14.22%
Short Float	1.21%
Short Ratio	2.63
Short Shares	0.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-4M
Average Volume	28,047x
Bv Per Share	1.03
CAPEX	$-2,044
Ch1m	-29.41
Ch1w	-28.56
Ch1y	-66.19
Ch3m	-41.69
Ch6m	-53.92
Change	0.86%
Change From Open	-2.08
Close	0.47
Days Gap	3
Depreciation Amortization	886,764.7
Dollar Volume	11,117.4
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-3.3M
EBITDA	$-2.5M
EPS	$-0.47
F Score	5
FCF	$-4M
FCF EV Yield	-52.9x
FCF Per Share	$-0.37
Financing CF	4,230,978
Fiscal Year End	June
Founded	2,018
Investing CF	-483,078
Ipr	-88.25
Iprfo	-88.25
Is Primary Listing	1
Is Spac	No
Last Report Date	2025-06-30
Last Split Type	Never
Last10k Filing Date	2025-11-17
Ma150	0.91
Ma150ch	-48.12%
Ma20	0.65
Ma20ch	-27.26%
Net CF	209,877
Next Earnings Date	2026-05-22
Open	0.48
Optionable	No
Position In Range	58.85
Post Close	0.47
Postmarket Change Percent	-5.06
Postmarket Price	$0.45
Ppne	11,534.2
Pre Close	0.47
Price Date	2026-05-08
Relative Volume	0.84x
Revenue	270,853x
Tr6m	-53.92%
Volume	23,654
Z Score	0.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GELS pay a dividend?

Capital-return profile for this ticker.

Performance

GELS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GELS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.7%

Float: +43.7% of shares outstanding

Insider ownership

+30.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GELS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.9

Below 30: short-term oversold

Price vs 200-day MA

-55.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GELS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GELS stock rating?

Gelteq Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GELS analysis?

The full report lives at /stocks/GELS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GELS?

The latest report frames GELS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GELS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.